Skip to main content

Table 1 Clinical characteristics of the study patients

From: Cytomegalovirus reactivation in immunocompetent mechanical ventilation patients: a prospective observational study

 

Overall

CMV reactivation

 
 

N = 71

Yes (n = 13, 18.3%)

No (n = 58, 81.7%)

P

Age (yr)

64 ± 14

68 ± 12

63 ± 14

0.20

Gender, n (%)

0.37

 Male

58 (81.7)

9 (69.2)

49 (84.5)

-

 Female

13 (18.3)

4 (30.8)

9 (15.5)

-

 Height (cm)

168 (160–171)

160 (160–167)

168 (160–172)

0.10

 Weight (kg)a

58.5 ± 11.8

51.1 ± 10.6

61.6 ± 11.6

0.01

 BMI (kg/m2) a

21.3 ± 3.6

19.9 ± 4.1

22.1 ± 3.4

0.03

Severity of Score

 APACHE II

20 ± 7

22 ± 8

20 ± 7

0.37

 SOFA

8 (5–11)

8 (5–10)

8 (6–11)

0.80

Comorbidities, n (%)

 Hypertension

34 (47.9)

6 (46.2)

28 (48.3)

0.89

 COPD

28 (39.4)

6 (46.2)

22 (37.9)

0.58

 Coronary Heart Disease

19 (26.8)

4 (30.8)

15 (25.9)

0.99

 Diabetes

18 (25.4)

2 (15.4)

16 (27.6)

0.58

 Chronic Kidney Disease

6 (8.5%)

1 (7.7)

5 (8.6)

NA

 Bronchiectasis

8 (11.3)

1 (7.7)

7 (12.1)

NA

 Asthma

2 (2.8)

1 (7.7)

1 (1.7)

0.34

 Rheumatic Heart Disease

1 (1.4)

0 (0)

1 (1.7)

NA

Complications, n (%)

 Surgical Factors

14 (19.7)

1 (7.7)

13 (22.4)

0.41

 Heart Surgery

13 (18.3)

1 (7.7)

12 (20.7)

0.49

 Trauma

1 (1.4)

0 (0)

1 (1.7)

NA

 Internal Medicine Factors

57 (80.3)

12 (92.3)

45 (77.6)

0.41

 Severe Pneumonia

48 (67.6)

10 (76.9)

38 (65.5)

0.64

 AECOPD

25 (35.2)

5 (38.5)

20 (34.5)

NA

 Sepsisa

18 (25.4)

7 (53.8)

11 (19.0)

0.02

 AKI

17 (23.9)

4 (30.8)

13 (22.4)

0.78

 Bronchiectasis Infection

8 (11.3)

1 (7.7)

7 (12.1)

NA

 ARDS

7 (9.9)

3 (23.1)

4 (6.9)

0.21

 Asthma Exacerbation

3 (4.2)

1 (7.7)

2 (3.4)

0.46

 Acute Coronary Syndrome

3 (4.2)

0 (0)

3 (5.2)

NA

 Heart Valve Disease

2 (2.8)

0 (0)

2 (3.4)

NA

 Liver Failure

1 (1.4)

0 (0)

1 (1.7)

NA

 Acute Suppurative Cholangitis

1 (1.4)

0 (0)

1 (1.7)

NA

  1. aP < 0.05; Continuous variables were expressed as Mean ± SD or Median (IQRs); Bold font indicates the difference was statistically significant. BMI Body Mass Index, APACHE II Acute Physiology and Chronic Health Evaluation, SOFA Sequential Organ Failure Assessment, COPD Chronic Obstructive Pulmonary Disease, AECOPD Acute Exacerbation of Chronic Obstructive Pulmonary Disease, AKI Acute Kidney Injury, ARDS Acute Respiratory Distress Syndrome